UBS AM’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.11M | Buy |
266,893
+81,657
| +44% | +$951K | ﹤0.01% | 1942 |
|
2025
Q1 | $1.38M | Buy |
185,236
+66,643
| +56% | +$495K | ﹤0.01% | 2173 |
|
2024
Q4 | $711K | Buy |
+118,593
| New | +$711K | ﹤0.01% | 2471 |
|
2024
Q2 | – | Sell |
-203,941
| Closed | -$655K | – | 2796 |
|
2024
Q1 | $655K | Buy |
203,941
+32,649
| +19% | +$105K | ﹤0.01% | 2200 |
|
2023
Q4 | $839K | Hold |
171,292
| – | – | ﹤0.01% | 2120 |
|
2023
Q3 | $934K | Buy |
171,292
+48,375
| +39% | +$264K | ﹤0.01% | 1990 |
|
2023
Q2 | $1.09M | Hold |
122,917
| – | – | ﹤0.01% | 1965 |
|
2023
Q1 | $1.09M | Buy |
122,917
+10,731
| +10% | +$94.8K | ﹤0.01% | 1965 |
|
2022
Q4 | $857K | Buy |
112,186
+2,457
| +2% | +$18.8K | ﹤0.01% | 1919 |
|
2022
Q3 | $781K | Buy |
109,729
+3,329
| +3% | +$23.7K | ﹤0.01% | 2113 |
|
2022
Q2 | $861K | Sell |
106,400
-65,243
| -38% | -$528K | ﹤0.01% | 2048 |
|
2022
Q1 | $2.38M | Buy |
171,643
+16,285
| +10% | +$226K | ﹤0.01% | 1711 |
|
2021
Q4 | $4.36M | Buy |
155,358
+4,558
| +3% | +$128K | ﹤0.01% | 1483 |
|
2021
Q3 | $5.13M | Buy |
150,800
+2,394
| +2% | +$81.4K | ﹤0.01% | 1341 |
|
2021
Q2 | $6.06M | Sell |
148,406
-130,715
| -47% | -$5.34M | ﹤0.01% | 1288 |
|
2021
Q1 | $11.2M | Buy |
279,121
+1,364
| +0.5% | +$54.9K | 0.01% | 1047 |
|
2020
Q4 | $16.4M | Buy |
277,757
+32,266
| +13% | +$1.91M | 0.01% | 897 |
|
2020
Q3 | $11.9M | Buy |
245,491
+10,779
| +5% | +$524K | 0.01% | 900 |
|
2020
Q2 | $11.4M | Buy |
234,712
+170,766
| +267% | +$8.26M | 0.01% | 872 |
|
2020
Q1 | $1.78M | Buy |
63,946
+12,923
| +25% | +$359K | ﹤0.01% | 1459 |
|
2019
Q4 | $1.53M | Sell |
51,023
-280
| -0.5% | -$8.38K | ﹤0.01% | 1719 |
|
2019
Q3 | $1.59M | Buy |
51,303
+1,303
| +3% | +$40.3K | ﹤0.01% | 1722 |
|
2019
Q2 | $2.42M | Buy |
+50,000
| New | +$2.42M | ﹤0.01% | 1489 |
|